Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Celcuity LLC
CELCCurrent price
18.73 USD
-0.68 USD (-3.50%)
Last closed
19.15 USD
Company
www.celcuity.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
641 297 088 USD
Yield for 12 month
+89.77 %
1Y
3Y
5Y
10Y
15Y
CELC
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota. Address: 16305?36th Avenue North, Minneapolis, MN, United States, 55446
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
28.8 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+229 648 USD
Current Year
-142 772 USD
Last Year
-210 918 USD
Current Quarter
-29 557 USD
Last Quarter
+201 700 USD
Key Figures CELC
1 year
3 years
5 years
10 years
EBITDA
-76 048 240 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-26.97 %
PEG Ratio
–
Return On Equity TTM
-57.17 %
Wall Street Target Price
28.8 USD
Revenue TTM
–
Book Value
4.35 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.78 USD
Diluted Eps TTM
-2.78 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CELC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CELC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CELC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-5.9941
Price Book MRQ
4.3727
Financials CELC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CELC
For 52 weeks
8.39 USD
22.19 USD
50 Day MA
16.21 USD
Shares Short Prior Month
1 895 116
200 Day MA
15.11 USD
Short Ratio
5.16
Shares Short
2 150 495
Short Percent
7.06 %
BeatStart